IL10 and allergic disease: It has been reported that the use of a TIM-1 specific antibody in a mouse asthma model can inhibit the occurrence and severity of airway hyperreactive inflammation by reducing the production of cytokines such as IL-10 and IL-13, and earlier studies have also mentioned that a positive hepatitis A virus reduces an individual's susceptibility to certain allergic diseases (54).